Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cameron Metcalf
Navigen, Inc., Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeuroAdjuvants, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The investigator's licensed intellectual property will be analyzed in the research. The investigator has a financial interest in NeuroAdjuvants, who holds the license to the technology. NeuroAdjuvants is partnering with Navigen in the development of galanin peptides for pain
Developing a Peripherally-Acting Peptidic Galanin Analog for Treatment of Postoperative Pain
The development of non-opioid analgesics for the control of postsurgical pain is widely acknowledged as an important goal. Side effects of opioids include respiratory depression, sedation, nausea, constipation, sleep impairment, and a high potential for abuse and addiction. Navigen is developing novel, metabolically stable, peripherally-restricted galanin analogs to replace or reduce the use of opioids in treatment of postoperative pain.
Filed on May 20, 2016.
Tell us what you know about Cameron Metcalf's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Cameron Metcalf”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Cameron Metcalf | Navigen, Inc. | Conflict of Interest | NeuroAdjuvants | Value cannot be readily determined |
| Cameron Metcalf | Navigen, Inc. | Conflict of Interest | University of Utah | Value cannot be readily determined |
| Cameron Metcalf | Navigen, Inc. | Conflict of Interest | University of Utah | Value cannot be readily determined |
| Cameron Metcalf | University of Utah | Conflict of Interest | N/A | Value cannot be determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.